Logo
C

Cardiol Therapeutics Inc.

23 employees

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pericarditis
Life Science
Formulation
Drug Delivery
Clinical-stage
Research
Heart Failure
Heart Disease
Myocarditis
Therapeutics
Nanotechnology
Heart

Date founded

2017

Funding rounds raised

Total raised

$17M

from 4 investors over 4 rounds

C

Cardiol Therapeutics Inc. raised $17M on May 13, 2020

Investors: Echelon Wealth Partners, AlbaCore Capital Group, Raymond James and Canaccord Financial

FAQ